Comparison of prognostic values of cardiopulmonary and heart rate parameters in exercise testing in men with heart failure

被引:2
|
作者
Czubaszewski, Lukasz [1 ]
Straburzynska-Lupa, Anna [1 ]
Migaj, Jacek [2 ]
Straburzynska-Migaj, Ewa [2 ]
机构
[1] Univ Phys Educ, Poznan, Poland
[2] Univ Med Sci, Univ Hosp Lords Transfigurat, Dept Cardiol 1, Poznan, Poland
关键词
chronotropic index; cardiopulmonary exercise testing; prognosis; chronic heart failure; CHRONOTROPIC INCOMPETENCE; VENTILATORY EFFICIENCY; VE/VCO2; SLOPE; PEAK VO2; INDEX; PREDICTOR; MORTALITY; OUTCOMES; SCORE;
D O I
10.5603/CJ.a2017.0070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiopulmonary exercise testing (CPET) is the gold standard in the evaluation of patients with chronic heart failure (CHF). However this test is relatively expensive, assessment of its results requires experience, and in Poland it is available only in tertiary health care centers. Many heart rate (HR) parameters taken during a standard electrocardiographic (ECG) exercise test also shows prognostic values. Thus, the aim of this study is to compare prognostic values of ventilatory and HR parameters in exercise testing in CHF patients, and to find out if HR parameters can be used instead of ventilatory in the evaluation of a prognosis. Methods: One hundred thirty two men (mean age 49 +/- 11 years) with CHF with reduced left ventricular ejection fraction (< 45%) underwent a treadmill CPET using a modified Bruce's protocol, during which both HR and ventilatory parameters were measured. The patients were followed for 27 +/- 13 months after CPET Results: Mortality was 28% (n = 37). Non-survivors demonstrated significantly shorter exercise time (342 +/- 167 vs. 525 +/- 342 s, p < 0.001), lower maximal HR (122 +/- 22 vs. 138 +/- 21 bpm, p < 0.001), smaller difference between maximal HR and at rest (36 +/- 19 vs. 52 +/- 21 bpm, p < 0.001), and lower HR recovery rate (HRR; 16 +/- 10 vs. 24 +/- 13 bpm, p = 0.002), chronotropic index (CHI; 0.45 +/- 0.23 vs. 0.61 +/- 0.23, p < 0.001), peak oxygen consumption (13.82 +/- 4.62 vs. 18.54 +/- 5.68 mL/kg/min, p < 0.001) and oxygen uptake efficiency slope (OUES) value (1.56 +/- 0.58 vs. 1.94 +/- 0.63, p = 0.001), and higher ventilation to carbon dioxide production (VE/VCO2) slope value (40.56 +/- 9.11 vs. 33.33 +/- 7.36, p < 0.001). Two parameters that showed good prognostic value and availability in a routine CPET were chosen for receiver operating characteristic analysis, VE/VCO2 slope and CHI, which showed cut- off values of 35 (sensitivity 74%, specificity 71%, p < 0.001) and 64 (sensitivity 74%, specificity 68%, p < 0.001) respectively. Conclusions: Heart rate parameters show significant prognostic values; CHI is the best of them, however it is weaker than VE/VCO2 slope. HR parameters show somewhat weaker prognostic values in comparison with ventilatory parameters, yet they may be useful in cases of CPET unavailability.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [21] A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure
    Cahalin, Lawrence P.
    Chase, Paul
    Arena, Ross
    Myers, Jonathan
    Bensimhon, Daniel
    Peberdy, Mary Ann
    Ashley, Euan
    West, Erin
    Forman, Daniel E.
    Pinkstaff, Sherry
    Lavie, Carl J.
    Guazzi, Marco
    [J]. HEART FAILURE REVIEWS, 2013, 18 (01) : 79 - 94
  • [22] Prognostic characteristics of cardiopulmonary exercise testing in heart failure: comparing American and European models
    Arena, R
    Guazzi, M
    Myers, J
    Peberdy, MA
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (06): : 562 - 567
  • [23] Different prognostic predictors in cardiopulmonary exercise testing according to the aetiology of systolic heart failure
    Christopher Strong, C. M. F.
    Dores, H.
    Mendes, M.
    Vale, N.
    Castro, M.
    Carmo, J.
    Mesquita, J.
    Guerreiro, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 492 - 493
  • [24] The Prognostic Utility of Cardiopulmonary Exercise Testing Stands the Test of Time in Patients With Heart Failure
    Arena, Ross
    Guazzi, Marco
    Myers, Jonathan
    Chase, Paul
    Bensimhon, Daniel
    Cahalin, Lawrence P.
    Peberdy, Mary Ann
    Ashley, Euan
    West, Erin
    Forman, Daniel E.
    [J]. JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2012, 32 (04) : 198 - 202
  • [25] A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure
    Lawrence P. Cahalin
    Paul Chase
    Ross Arena
    Jonathan Myers
    Daniel Bensimhon
    Mary Ann Peberdy
    Euan Ashley
    Erin West
    Daniel E. Forman
    Sherry Pinkstaff
    Carl J. Lavie
    Marco Guazzi
    [J]. Heart Failure Reviews, 2013, 18 : 79 - 94
  • [26] Prognostic value of cardiopulmonary exercise testing in heart failure patients with preserved systolic function
    Arena, R
    Guazzi, M
    Myers, J
    [J]. CIRCULATION, 2004, 110 (17) : 534 - 534
  • [27] Prognostic value of cardiopulmonary exercise testing in heart failure patients with preserved systolic function
    Guazzi, M
    Arena, R
    Myers, J
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S106 - S106
  • [28] Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure
    Ingle, Lee
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 112 - 118
  • [29] Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
    Isnard, R
    Pousset, F
    Trochu, JN
    Chafirovskaïa, O
    Carayon, A
    Golmard, JL
    Lechat, P
    Thomas, D
    Bouhour, JB
    Komajda, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (04): : 417 - 421
  • [30] Prognostic Prediction of Cardiopulmonary Exercise Test Parameters in Heart Failure Patients with Atrial Fibrillation
    Goncalves, Antonio Valentim
    Pereira-da-Silva, Tiago
    Soares, Rui
    Feliciano, Joana
    Moreira, Rita Ilhao
    Rio, Pedro
    Abreu, Ana
    Ferreira, Rui Cruz
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (02) : 209 - 217